Spark Therapeutics is classified as operating in the Physicians, Mental Health Specialists industry, NAICS Code 621112.
Spark Therapeutics is a publicly traded company on NMS using the ticker symbol ONCE.
Detailed information on company financials and operating reports can be found here:
NMS: ONCE
Note: Spark Therapeutics's revenues are gauged from an analysis of company filings.
Investor Activity
Spark Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
June 6, 2014
28
100%
$73 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Spark Therapeutics is developing and marketing.
Spark Therapeutics's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
FERMATA Providing medical and scientific research information in the field of clinical trials relating to Fabry disease; Scientific research in the nature of conducting clinical trials for others in the field of Fabry disease; Pharmaceutical research and development in the field of Fabry disease
10/03/2023
MLMT Ophthalmology services; optometry services; vision screenings; medical testing, namely, eye and vision testing
03/04/2023
DIRLOC Providing medical research information in the field of clinical trials in relation to hemophilia; medical research in the field of hemophilia
02/15/2023
See all trademarks and details in the Full Report.
Market Share of Spark Therapeutics's Largest Competitors
A competitive analysis shows these companies are in the same general field as Spark Therapeutics, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Spark Therapeutics.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Spark Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.